Galaxy Medicare (NSE:GML) Notes Receivable: ₹0.0 Mil (As of Mar. 2026)


NSE:GML Galaxy Medicare Ltd NSE:GML
19 GF Score
Price ₹18.30
! 2 Warning Signs
View Full Analysis

What is Galaxy Medicare Notes Receivable?

Galaxy Medicare NSE:GML 19 Notes Receivable is ₹0.0 Mil as of Mar. 2026. GuruFocus rates NSE:GML with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

Galaxy Medicare's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Galaxy Medicare Notes Receivable Related Terms

Galaxy Medicare Notes Receivable Historical Data

* Premium members only.

The historical data trend for Galaxy Medicare's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galaxy Medicare Notes Receivable Chart

Galaxy Medicare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Galaxy Medicare Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:GML
19GF Score
Galaxy Medicare Ltd NSE:GML
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galaxy Medicare Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.0 Mil mean?
Galaxy Medicare (NSE:GML) has a Notes Receivable of ₹0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Galaxy Medicare and its competitors.
Is Galaxy Medicare's Notes Receivable too high?
Galaxy Medicare's current Notes Receivable is ₹0.0 Mil. Overall, Galaxy Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Galaxy Medicare's Notes Receivable compare to ISRG and BDX?
Galaxy Medicare's Notes Receivable of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Galaxy Medicare and its competitors. Galaxy Medicare's current Notes Receivable is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galaxy Medicare stock overvalued right now?
Galaxy Medicare (NSE:GML) has a current Notes Receivable of ₹0.0 Mil. The current Notes Receivable is ₹0.0 Mil. Galaxy Medicare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Galaxy Medicare (NSE:GML), the current Notes Receivable is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galaxy Medicare Business Description

Address Plot No-2, Zone D, Phase A, Mancheswar Industrial Estate, Khurda, Bhubaneswar, OR, IND, 751010
Galaxy Medicare Ltd is engaged into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India. Its business encompass: Manufacturing and Branding of its own products under its flagship brands i.e. POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, FIXCAN ETC.
19GF Score

Get the complete analysis for NSE:GML

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹18.30
Price